Difficulty: Medium
Average Score: 84%
Practice
We have two patients; one requires suppression of emesis caused by an anticancer drug. Another patient has severe diabetic gastroparesis and gastroesophageal reflux, which requires relief. Which drug would be most suitable for both indications?
Correct answer
D
Rationale
The most suitable drug for both indications of suppressing emesis caused by an anticancer drug and providing relief for severe diabetic gastroparesis and gastroesophageal reflux is Metoclopramide (Option D).
Metoclopramide is a prokinetic agent that works by enhancing gastrointestinal motility and increasing lower esophageal sphincter tone. It is effective in treating nausea and vomiting by acting on the central nervous system to inhibit dopamine receptors. This mechanism makes it useful in managing chemotherapy-induced emesis and diabetic gastroparesis with reflux symptoms.
Option A, Diphenoxylate, is an opioid used for treating diarrhea, not emesis or gastroparesis. Option B, Aprepitant, is a neurokinin-1 receptor antagonist primarily used for chemotherapy-induced nausea and vomiting, not diabetic gastroparesis or reflux. Option C, Pyridoxine, is a form of vitamin B6 used for various conditions but not specifically indicated for these gastrointestinal issues.
In an educational context, understanding the mechanisms of action and specific indications of gastrointestinal drugs is crucial for effective clinical decision-making. By grasping the pharmacology of drugs like Metoclopramide, healthcare providers can appropriately select the most suitable treatment options for patients based on their conditions and symptoms.
Metoclopramide is a prokinetic agent that works by enhancing gastrointestinal motility and increasing lower esophageal sphincter tone. It is effective in treating nausea and vomiting by acting on the central nervous system to inhibit dopamine receptors. This mechanism makes it useful in managing chemotherapy-induced emesis and diabetic gastroparesis with reflux symptoms.
Option A, Diphenoxylate, is an opioid used for treating diarrhea, not emesis or gastroparesis. Option B, Aprepitant, is a neurokinin-1 receptor antagonist primarily used for chemotherapy-induced nausea and vomiting, not diabetic gastroparesis or reflux. Option C, Pyridoxine, is a form of vitamin B6 used for various conditions but not specifically indicated for these gastrointestinal issues.
In an educational context, understanding the mechanisms of action and specific indications of gastrointestinal drugs is crucial for effective clinical decision-making. By grasping the pharmacology of drugs like Metoclopramide, healthcare providers can appropriately select the most suitable treatment options for patients based on their conditions and symptoms.